1
Clinical Trials associated with Autologous Tolerogenic Dendritic Cell(Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus)A Phase ½ Study to Evaluate the Safety and Feasibility of Autologous Tolerogenic Dendritic Cells in Patients With Type 1 Diabetes Mellitus
The purpose of this study is to determine the safety and tolerability of the administration of tolerogenic dendritic cells in patients with type 1 diabetes mellitus.
100 Clinical Results associated with Autologous Tolerogenic Dendritic Cell(Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus)
100 Translational Medicine associated with Autologous Tolerogenic Dendritic Cell(Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus)
100 Patents (Medical) associated with Autologous Tolerogenic Dendritic Cell(Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus)
100 Deals associated with Autologous Tolerogenic Dendritic Cell(Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus)